home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Primate Patient-Specific Stem Cells

  November, 14 2007 18:51
your information resource in human molecular genetics
A method of reprogramming rhesus macaque adult fibroblasts into embryonic stem cells using somatic cell nuclear transfer is presented in Nature. Shoukhrat Mitalipov and colleagues injected an adult fibroblast nucleus into an oocyte with its own nucleus removed. They then induced an early-stage embryo called a blastocyst, and teased out and cultured embryonic stem cells.

Although cloning of embryos has been achieved in several species, until now scientists have not achieved this in primates. Furthermore, creating embryonic stem cells via somatic cell nuclear transfer has only been achieved in mice. It is thought that in humans, such embryonic stem cells could be used to treat a variety of diseases without immune rejection, as they could be tailored to individual patients.

The team generated two embryonic stem cell lines from 304 oocytes taken from 14 rhesus monkeys, a 0.7% derivation efficiency from oocytes. Their success with primates suggests that this approach might work in humans for the purpose of generating patient-derived embryonic stem cells.

In a related News and Views article, Ian Wilmut and Jane Taylor discuss the potential of such cells not only for treating diseases but to understand the genetics of disease: 'In our haste to use patient-specific cells in therapy, however, we tend to overlook that they have great value for basic research and drug discovery. For example, such cells could provide new ways to study inherited diseases' they say.

In addition to the paper, an independent team carried out an experimental validation of the research. David Cram and colleagues confirm that the cells have indeed been produced by cloning, and their related report will be published online at the same time and with the same embargo.


Shoukhrat M. Mitalipov (Oregon Health & Science University, Beaverton, OR, USA)
E-mail: mitalipo@ohsu.edu

Ian Wilmut (University of Edinburgh, UK)
E-mail: ian.wilmut@ed.ac.uk

David Cram (Monash University, Melbourne, Australia)
E-mail: david.cram@med.monash.edu.au

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.